人口老龄化和疾病谱变化导致的各种慢性创面日趋增多,不仅迁延难愈,给患者带来身心痛苦,致其生存质量低下,也给家庭和社会造成沉重负担。实践证明,建立创面修复科对慢性创面进行专科化治疗是提高治疗水平的有效途径。我国创面修复科作为一个新的外科三级学科已经创建5年,笔者对创面修复学科创建过程中面临的主要困难进行梳理。针对这些问题,笔者从提高思想认识、建设标准病房及探索多种学科建设模式、推动研究型学科建设、明确收治范围、争取服务项目与推动专科四级手术体系建立、制订系列共识指南规范治疗、创面修复系列新技术研发与转化应用、创面修复人才教育培训体系建立、学术交流与合作、推进名科建设等方面探讨重要举措及取得的成就,为持续推进创面修复学科建设提供参考。
The aging population and changes in the disease spectrum have contributed to an increasing number of chronic refractory wounds, which not only cause physical and mental pain to patients and diminish their life quality, but also place a heavy burden on both their families and the society. Clinical practice has proven that establishing wound repair department for specialized treatment of chronic refractory wounds can effectively enhance treatment outcomes. As a newly established tertiary surgical discipline, wound repair discipline in China has been in development for 5 years. The authors outlined the main difficulties encountered during the establishment of wound repair discipline and summarized the key issues over the past 5 years. To solve these difficulties, the authors reviewed measures and achievements in areas such as raising people′s awareness, building standardized wards, exploring the multiple models of discipline construction, advancing research-oriented discipline construction, defining the scope of treatment, striving for service projects and promoting establishment of specialized level IV surgical systems, formulating a series of consensus guidelines for standardized treatment, developing and translating new wound repair technologies, creating a talent education and training system, expanding academic exchanges and cooperation, as well as fostering the growth of high-level disciplines, so as to offer references to support ongoing advancement in the establishment of wound repair discipline.
黄跃生,付小兵. 我国创面修复学科创建5年面临的困难与取得的成就[J]. 中华创伤杂志,2025,41(03):225-230.
DOI:10.3760/cma.j.cn501098-20241223-00718版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。